Filing Details
- Accession Number:
- 0001493152-24-035753
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-11 11:57:14
- Reporting Period:
- 2024-09-09
- Accepted Time:
- 2024-09-11 11:57:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 862861 | Alt5 Sigma Corp | ALTS | Pharmaceutical Preparations (2834) | 411454591 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1724514 | Peter Tassiopoulos | 325 E. Warm Springs Road Suite 102 Las Vegas NV 89119 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-09-09 | 5,000 | $2.06 | 420,000 | No | 4 | P | Indirect | Shares are beneficially owned through a Canadian registered retirement savings plan |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | Shares are beneficially owned through a Canadian registered retirement savings plan |
Billionaire Hedge Funds
